Bristol Myers Squibb Co
BMYNYSECIK 14272HealthcareFiscal year ends Dec 31
Reports and events: 353 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2907:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-26-000022 |
| 2026-07-3011:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000014272-26-000020 |
| 2026-07-3007:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-26-000018 |
| 2026-05-0816:10 ET | 8-K | 5.07 Shareholder vote results | 0001140361-26-020036 |
| 2026-04-3011:44 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000014272-26-000010 |
| 2026-04-3007:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-26-000008 |
| 2026-03-2516:19 ET | DEF 14A | Proxy statementPeriod 2026-05-05 | 0000014272-26-000006 |
| 2026-02-1111:35 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000014272-26-000004 |
| 2026-02-0507:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-26-000002 |
| 2026-01-1210:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-000929 |
| 2025-11-1816:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-042607 |
| 2025-11-1016:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-041380 |
| 2025-11-0306:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-040066 |
| 2025-10-3012:04 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000014272-25-000149 |
| 2025-10-3007:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-25-000147 |
| 2025-07-3112:17 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000014272-25-000131 |
| 2025-07-3107:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-25-000129 |
| 2025-07-2516:43 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-027350 |
| 2025-05-0717:04 ET | 8-K | 5.07 Shareholder vote results | 0001140361-25-017742 |
| 2025-04-2411:45 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000014272-25-000091 |
| 2025-04-2407:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-25-000089 |
| 2025-03-2616:18 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0000014272-25-000075 |
| 2025-02-1816:35 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-25-005012 |
| 2025-02-1212:52 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000014272-25-000039 |
| 2025-02-0607:46 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-25-000037 |
| 2025-01-1310:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-000885 |
| 2024-10-3111:43 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000014272-24-000147 |
| 2024-10-3107:52 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-24-000145 |
| 2024-07-2612:04 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000014272-24-000123 |
| 2024-07-2607:46 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-24-000121 |
| 2024-06-1816:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-24-030533 |
| 2024-05-0916:53 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-24-025213 |
| 2024-04-2512:38 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000014272-24-000096 |
| 2024-04-2507:47 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-24-000094 |
| 2024-03-2817:16 ET | DEF 14A | Proxy statementPeriod 2024-05-07 | 0001140361-24-016251 |
| 2024-03-1817:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-24-013978 |
| 2024-03-1808:56 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-013726 |
| 2024-02-2216:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-009040 |
| 2024-02-1516:57 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-24-008198 |
| 2024-02-1416:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-008013 |
| 2024-02-1311:54 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000014272-24-000044 |
| 2024-02-0207:46 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-24-000020 |
| 2024-01-0810:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-001288 |
| 2023-12-2216:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-059159 |
| 2023-11-1316:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-052908 |
| 2023-10-3116:30 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001140361-23-050518 |
| 2023-10-2612:33 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000014272-23-000181 |
| 2023-10-2607:44 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000014272-23-000179 |
| 2023-08-1007:10 ET | 8-K | 8.01 Other events | 0001140361-23-038900 |
| 2023-07-2712:28 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000014272-23-000152 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 11:17 ET. Listed shows no prices and gives no investment advice.